Evidence map›Paper›PMID 36302103›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2022

International normalized ratio and activated partial thromboplastin time testing.

Nicholas L J Chornenki, Michael Fralick, Michelle Sholzberg

Abstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. "TEG" talks: technology worth spreading?Research and practice in thrombosis and haemostasis · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicholas L J ChornenkiDepartment of Medicine (Chornenki), Queen's University, Kingston, Ont.; Division of General Internal Medicine (Fralick), Sinai Health, and Departments of Medicine, and Laboratory Medicine and Pathobiology (Sholzberg), St Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ont. 20NLJC@queensu.ca.
Michael FralickDepartment of Medicine (Chornenki), Queen's University, Kingston, Ont.; Division of General Internal Medicine (Fralick), Sinai Health, and Departments of Medicine, and Laboratory Medicine and Pathobiology (Sholzberg), St Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ont.
Michelle SholzbergDepartment of Medicine (Chornenki), Queen's University, Kingston, Ont.; Division of General Internal Medicine (Fralick), Sinai Health, and Departments of Medicine, and Laboratory Medicine and Pathobiology (Sholzberg), St Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ont.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnticoagulantsHumansInternational Normalized RatioPartial Thromboplastin TimeAnticoagulants

Identifiers

PMID36302103
PMCPMC9435534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.